专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20070150323A1 Method and system for generating supply chain planning information 审中-公开
标题翻译：供应链计划信息的生成方法和系统
公开(公告)号：US20070150323A1
公开(公告)日：2007-06-28
申请号：US11471555
申请日：2006-06-21
申请人： June-Ray Lin , Chi-Hung Huang , Chun-Kai Wang , Chia-Chun Shih
发明人： June-Ray Lin , Chi-Hung Huang , Chun-Kai Wang , Chia-Chun Shih
IPC分类号： G06F17/50
CPC分类号： G06Q10/04 , G06Q10/06 , G06Q10/0631 , G06Q10/06314 , G06Q10/06315 , G06Q10/0637 , G06Q10/06375
摘要： A method and a system for generating supply chain planning information are provided, which are used to dynamically adjust the control factors of the supply information provided by an original supplier and an original logistics provider, after the first supply chain planning information has been generated through a conventional supply chain planning information system, so as to generate much more supply information to process. Then, the information is processed by a planning engine of the supply chain planning information system to further generate other supply chain planning information among which to select in decision making. Hence, a decision maker can select and find out improved ways to negotiate with suppliers, so as to reduce the total cost and also meet customers' service quality requirements.
摘要翻译：提供了一种生成供应链计划信息的方法和系统，用于动态调整由原始供应商和原始物流供应商提供的供应信息的控制因素，在第一个供应链计划信息通过常规供应链计划信息系统，从而产生更多的供应信息来处理。然后，信息由供应链计划信息系统的规划引擎处理，以进一步产生其他供应链计划信息，在决策中选择其中。因此，决策者可以选择和找出改进的方式与供应商进行谈判，从而降低总成本并满足客户的服务质量要求。

2. 发明申请

US20110092450A1 METHOD OF ENHANCING THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS USING TAT-HOXB4H 有权
标题翻译：使用TAT-HOXB4H增强HEMATOPOIETIC干细胞移动的方法
公开(公告)号：US20110092450A1
公开(公告)日：2011-04-21
申请号：US12906435
申请日：2010-10-18
申请人： Kou-Juey Wu , Chi-Hung Huang
发明人： Kou-Juey Wu , Chi-Hung Huang
IPC分类号： A61K38/16 , A61P43/00
CPC分类号： C07K14/475 , A61K38/00 , C07K2319/21
摘要： The present invention relates to a new and nonobvious method of producing the C-terminal histidine tagged TAT-HOXB4 fusion protein (TAT-HOXB4H), providing unexpected benefits of increased yield and stability to allow for in vivo administration of this protein, and pharmaceutical composition comprising an effective ingredient, TAT-HOXB4H, having stimulatory activity on the production of hematopoietic cells. More specifically, recombinant TAT-HOXB4H protein enhances engraftment of bone marrow transplants, hematopoietic reconstruction, bone marrow re-population and number of circulating stem cells, particularly after chemotherapy or irradiation.
摘要翻译：本发明涉及生产C-末端组氨酸标记的TAT-HOXB4融合蛋白（TAT-HOXB4H）的新的和非显而易见的方法，提供增加产量和稳定性以允许体内施用该蛋白质的意想不到的好处，以及药物组合物包括对造血细胞产生具有刺激活性的有效成分TAT-HOXB4H。更具体地说，重组TAT-HOXB4H蛋白增强了骨髓移植物的移植，造血重建，骨髓重新种群和循环干细胞的数量，特别是化疗或照射后。

3. 发明申请

US20090110271A1 COLOR RECOGNITION DEVICE AND METHOD THEREOF 审中-公开
标题翻译：彩色识别装置及其方法
公开(公告)号：US20090110271A1
公开(公告)日：2009-04-30
申请号：US11965129
申请日：2007-12-27
申请人： Yu-Chieh Chen , Tai-Shan Liao , Chi-Hung Huang , Chien-Jen Chen
发明人： Yu-Chieh Chen , Tai-Shan Liao , Chi-Hung Huang , Chien-Jen Chen
IPC分类号： G06K9/00
CPC分类号： G09B21/008 , G06K9/00825
摘要： A color recognition device is provided. The color recognition device includes a color image sensor, an image processing system, and a projection device. The color image sensor senses a color image having an image area with a specific color, and generates a first electrical signal corresponding to the color image. The image processing system receives the first electrical signal, modifies the color image, and generates a second electrical signal. The projection device receives the second electrical signal, and projects a modified image corresponding to the second electrical signal.
摘要翻译：提供了一种颜色识别装置。颜色识别装置包括彩色图像传感器，图像处理系统和投影装置。彩色图像传感器感测具有特定颜色的图像区域的彩色图像，并且生成与彩色图像对应的第一电信号。图像处理系统接收第一电信号，修改彩色图像，并产生第二电信号。投影装置接收第二电信号，投影与第二电信号对应的修正图像。

4. 发明授权

US06263128B1 Fiber unbalanced Mach-Zehnder interferometers with flat-top spectral response for application in wavelength division multiplexers 失效
标题翻译：光纤不平衡马赫 - 曾德干涉仪，具有平顶光谱响应，适用于波分复用器
公开(公告)号：US06263128B1
公开(公告)日：2001-07-17
申请号：US09324238
申请日：1999-06-02
申请人： Chi-Hung Huang
发明人： Chi-Hung Huang
IPC分类号： G02B628
CPC分类号： G02B6/29352 , G02B6/29319 , G02B6/29358 , G02B6/2938
摘要： According to the present invention, a multi-window wavelength division multiplexer (MWDM) is coupled to a correcting filter characterized by a shallow modulation depth and a channel separation smaller than the MWDM. A correcting filter is coupled to an input of the MWDM or to each of the two outputs of the MWDM. By changing the modulation depth and/or channel separation of the correcting filter(s), the spectral response of the filter can be adjusted to produce a more uniform gain (i.e., a “flat-top” spectral response) across wavelengths of passbands within the MWDM. In one embodiment, the correcting filter is an unbalanced Mach-Zehnder interferometer formed with two fused-fiber couplers having non-equal splitting ratios. In other embodiments, the correcting filter is a Fabry-Perot interferometer having a low end-face reflectivity.
摘要翻译：根据本发明，多窗口波分多路复用器（MWDM）耦合到校正滤波器，其特征在于浅调制深度和小于MWDM的信道分离。校正滤波器耦合到MWDM的输入或MWDM的两个输出中的每一个。通过改变校正滤波器的调制深度和/或信道间隔，可以调整滤波器的频谱响应，以在多个通带波长内产生更均匀的增益（即，“平顶”频谱响应） MWDM。在一个实施例中，校正滤波器是由具有不相等分离比的两个熔接光纤耦合器形成的不平衡马赫 - 曾德干涉仪。在其他实施例中，校正滤波器是具有低端面反射率的法布里 - 珀罗干涉仪。

5. 发明授权

US08222207B2 Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H 有权
标题翻译：使用TAT-HOXB4H增强造血干细胞动员的方法
公开(公告)号：US08222207B2
公开(公告)日：2012-07-17
申请号：US12906435
申请日：2010-10-18
申请人： Kou-Juey Wu , Chi-Hung Huang
发明人： Kou-Juey Wu , Chi-Hung Huang
IPC分类号： A61P7/00 , A61P37/00 , A61K38/00
CPC分类号： C07K14/475 , A61K38/00 , C07K2319/21
摘要： The present invention relates to a new and nonobvious method of producing the C-terminal histidine tagged TAT-HOXB4 fusion protein (TAT-HOXB4H), providing unexpected benefits of increased yield and stability to allow for in vivo administration of this protein, and pharmaceutical composition comprising an effective ingredient, TAT-HOXB4H, having stimulatory activity on the production of hematopoietic cells. More specifically, recombinant TAT-HOXB4H protein enhances engraftment of bone marrow transplants, hematopoietic reconstruction, bone marrow re-population and number of circulating stem cells, particularly after chemotherapy or irradiation.
摘要翻译：本发明涉及生产C-末端组氨酸标记的TAT-HOXB4融合蛋白（TAT-HOXB4H）的新的和非显而易见的方法，提供增加产量和稳定性以允许体内施用该蛋白质的意想不到的好处，以及药物组合物包括对造血细胞产生具有刺激活性的有效成分TAT-HOXB4H。更具体地说，重组TAT-HOXB4H蛋白增强了骨髓移植物的移植，造血重建，骨髓重新种群和循环干细胞的数量，特别是化疗或照射后。

6. 发明申请

US20120015908A1 SYNTHESIS AND ANTICANCER ACTIVITY OF ARYL AND HETEROARYL-QUINOLIN DERIVATIVES 有权
标题翻译：芳基和喹啉衍生物的合成和反应活性
公开(公告)号：US20120015908A1
公开(公告)日：2012-01-19
申请号：US13181978
申请日：2011-07-13
申请人： Sheng-Chu Kuo , Kuo-Hsiung Lee , Li-Jiau Huang , Li-Chen Chou , Tian-Shung Wu , Tzong-Der Way , Jing-Gung Chung , Jai-Sing Yang , Chi-Hung Huang , Meng-Tung Tsai
发明人： Sheng-Chu Kuo , Kuo-Hsiung Lee , Li-Jiau Huang , Li-Chen Chou , Tian-Shung Wu , Tzong-Der Way , Jing-Gung Chung , Jai-Sing Yang , Chi-Hung Huang , Meng-Tung Tsai
IPC分类号： A61K31/675 , A61K31/47 , C07D491/056 , A61K31/4741 , C07F9/60 , A61P35/00 , A61K31/5377 , C07D405/14 , A61K31/4709 , C07D413/10 , C07D401/10 , C07D215/233 , C07D413/14
CPC分类号： C07D493/04 , C07D215/22 , C07D215/233 , C07D215/38 , C07D401/04 , C07F9/60 , C07F9/65583 , C07F9/6561
摘要： A compound of Formula I is disclosed as follows: or a pharmaceutically acceptable salt, prodrug, solvate, or metabolite thereof, wherein R is hydrogen, P(═O)(OH)2, P(═O)(O(C1-C18)alkylene(C6-C20)aryl)2, P(═O)(OH)(OM), P(═O)(OM)2, P═O(O2M), S(═O)(OH)2, S(═O)(O(C1-C18)alkylene(C6-C20)aryl)2, S(═O)(OH)(OM), S(═O)(OM)2; M is a monovalent or divalent metal ion, or alkylammonium ion; W is (C6-C20)aryl, (C6-C20)heteroaryl, (C1-C18)alkyl(C6-C20)aryl, (C1-C18)alkyl(C6-C20)heteroaryl, hydroxy(C6-C20)aryl, hydroxy(C6-C20)heteroaryl, (C1-C18)alkoxy(C6-C20)aryl, (C1-C18)alkoxy(C6-C20)heteroaryl, (C1-C18)alkylenedioxy(C6-C20)aryl, (C1-C18)alkylenedioxy(C6-C20)heteroaryl, halo(C6-C20)aryl, halo(C6-C20)heteroaryl, (C1-C18)alkylamino(C6-C20)aryl, (C1-C18)alkylamino(C6-C20)heteroaryl, (C1-C18)cycloalkylamino(C6-C20)aryl, or (C1-C18)cycloalkylamino(C6-C20)heteroaryl, and their OR8 substutes; R5 is (C1-C18alkoxy, hydrogen, hydroxyl, O—(C1-C18)alkyl(C6-C20)aryl, halo or OR8, or R5 and R6 are (C1-C18)dioxy provided that R7 is hydrogen; R6 is hydroxyl, O—(C1-C18)alkyl(C6-C20)aryl, halo or ORR, (C1-C18)alkoxy, (C1-C18)alkylamino, or (C1-C18)cycloalkylamino, or R6 and R7 are (C1-C18)dioxy provided that R5 is hydrogen; R7 is hydrogen, halo or OR8, hydroxyl, or O—(C1-C18)alkyl(C6-C20)aryl; and R8 is P(═O)(OH)2, P(═O)(O(C1-C18)alkyl(C6-C20)aryl)2, P(═O)(OH)(OM), or P(═O)(OM)2, P═O(O2M).
摘要翻译：式I的化合物公开如下：或其药学上可接受的盐，前药，溶剂合物或代谢物，其中R是氢，P（= O）（OH）2，P（= O）（O（C 1 -C 18））亚烷基（C 6 -C 20）芳基）2，P（= O）（OH）（OM），P（= O）（OM）2，P = O（O 2 M） S（ΟO）（O（C1-C18）亚烷基（C6-C20）芳基）2，S（═0）（OH）（OM），S（ΟO）（OM） M是一价或二价金属离子或烷基铵离子; W是（C 6 -C 20）芳基，（C 6 -C 20）杂芳基，（C 1 -C 18）烷基（C 6 -C 20）芳基，（C 1 -C 18）烷基（C 6 -C 20）羟基（C 6 -C 20）杂芳基，（C 1 -C 18）烷氧基（C 6 -C 20）芳基，（C 1 -C 18）烷氧基（C 6 -C 20）杂芳基，（C 1 -C 18）亚烷基二氧基 C 1 -C 20烷基氨基（C 6 -C 20）芳基，（C 1 -C 20）芳基，（C 1 -C 20）芳基，杂芳基，（C1-C18）环烷基氨基（C6-C20）芳基或（C1-C18）环烷基氨基（C6-C20）杂芳基及其OR8分子; R5是（C1-C18烷氧基，氢，羟基，O-（C1-C18）烷基（C6-C20）芳基，卤素或OR8或R5和R6是（C1-C18）二氧基，条件是R7是氢; R6是羟基，（C 1 -C 18）烷基（C 6 -C 20）芳基，卤素或ORR，（C 1 -C 18）烷氧基，（C 1 -C 18）烷基氨基或（C 1 -C 18）环烷基氨基或R 6和R 7为其中R 5为氢，R 7为氢，卤素或OR 8，羟基或O-（C 1 -C 18）烷基（C 6 -C 20）芳基; R 8为P（= O）（OH）2，P （O）（O（C1-C18）烷基（C6-C20）芳基）2，P（= O）（OH）（OM）或P（= O）（OM）2，P = O（O2M）。

7. 发明授权

US08524740B2 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives 有权
标题翻译：芳基和杂芳基 - 喹啉衍生物的合成和抗癌活性
公开(公告)号：US08524740B2
公开(公告)日：2013-09-03
申请号：US13181978
申请日：2011-07-13
申请人： Sheng-Chu Kuo , Kuo-Hsiung Lee , Li-Jiau Huang , Li-Chen Chou , Tian-Shung Wu , Tzong-Der Way , Jing-Gung Chung , Jai-Sing Yang , Chi-Hung Huang , Meng-Tung Tsai
发明人： Sheng-Chu Kuo , Kuo-Hsiung Lee , Li-Jiau Huang , Li-Chen Chou , Tian-Shung Wu , Tzong-Der Way , Jing-Gung Chung , Jai-Sing Yang , Chi-Hung Huang , Meng-Tung Tsai
IPC分类号： A61K31/04 , C07D215/04
CPC分类号： C07D493/04 , C07D215/22 , C07D215/233 , C07D215/38 , C07D401/04 , C07F9/60 , C07F9/65583 , C07F9/6561
摘要： A compound of Formula I is disclosed as follows: or a pharmaceutically acceptable salt, prodrug, solvate, or metabolite thereof, wherein R is hydrogen, P(═O)(OH)2, P(═O)(O(C1-C18)alkylene(C6-C20)aryl)2, P(═O)(OH)(OM), P(═O)(OM)2, P═O(O2M), S(═O)(OH)2, S(═O)(O(C1-C18)alkylene(C6-C20)aryl)2, S(═O)(OH)(OM), S(═O)(OM)2; M is a monovalent or divalent metal ion, or alkylammonium ion; W is (C6-C20)aryl, (C6-C20)heteroaryl, (C1-C18)alkyl(C6-C20)aryl, (C1-C18)alkyl(C6-C20)heteroaryl, hydroxy(C6-C20)aryl, hydroxy(C6-C20)heteroaryl, (C1-C18)alkoxy(C6-C20)aryl, (C1-C18)alkoxy(C6-C20)heteroaryl, (C1-C18)alkylenedioxy(C6-C20)aryl, (C1-C18)alkylenedioxy(C6-C20)heteroaryl, halo(C6-C20)aryl, halo(C6-C20)heteroaryl, (C1-C18)alkylamino(C6-C20)aryl, (C1-C18)alkylamino(C6-C20)heteroaryl, (C1-C18)cycloalkylamino(C6-C20)aryl, or (C1-C18)cycloalkylamino(C6-C20)heteroaryl, and their OR8 substutes; R5 is (C1-C18alkoxy, hydrogen, hydroxyl, O—(C1-C18)alkyl(C6-C20)aryl, halo or OR8, or R5 and R6 are (C1-C18)dioxy provided that R7 is hydrogen; R6 is hydroxyl, O—(C1-C18)alkyl(C6-C20)aryl, halo or OR8, (C1-C18)alkoxy, (C1-C18)alkylamino, or (C1-C18)cycloalkylamino, or R6 and R7 are (C1-C18)dioxy provided that R5 is hydrogen; R7 is hydrogen, halo or OR8, hydroxyl, or O—(C1-C18)alkyl(C6-C20)aryl; and R8 is P(═O)(OH)2, P(═O)(O(C1-C18)alkyl(C6-C20)aryl)2, P(═O)(OH)(OM), or P(═O)(OM)2, P═O(O2M).
摘要翻译：式I化合物公开如下：或其药学上可接受的盐，前药，溶剂合物或代谢物，其中R是氢，P（= O）（OH）2，P（= O）（O（C 1 -C 18））亚烷基（C 6 -C 20）芳基）2，P（= O）（OH）（OM），P（= O）（OM）2，P = O（O 2 M） S（= O）（O（C1-C18）亚烷基（C6-C20）芳基）2，S（= O）（OH）（OM），S（= O）（OM） M是一价或二价金属离子或烷基铵离子; W是（C 6 -C 20）芳基，（C 6 -C 20）杂芳基，（C 1 -C 18）烷基（C 6 -C 20）芳基，（C 1 -C 18）烷基（C 6 -C 20）羟基（C 6 -C 20）杂芳基，（C 1 -C 18）烷氧基（C 6 -C 20）芳基，（C 1 -C 18）烷氧基（C 6 -C 20）杂芳基，（C 1 -C 18）亚烷基二氧基 C 1 -C 20烷基氨基（C 6 -C 20）芳基，（C 1 -C 20）芳基，（C 1 -C 20）芳基，杂芳基，（C1-C18）环烷基氨基（C6-C20）芳基或（C1-C18）环烷基氨基（C6-C20）杂芳基及其OR8分子; R5是（C1-C18烷氧基，氢，羟基，O-（C1-C18）烷基（C6-C20）芳基，卤素或OR8或R5和R6是（C1-C18）二氧基，条件是R7是氢; R6是羟基，（C 1 -C 18）烷基（C 6 -C 20）芳基，卤素或OR 8，（C 1 -C 18）烷氧基，（C 1 -C 18）烷基氨基或（C 1 -C 18）环烷基氨基或R 6和R 7为（C 1 -C 18）烷基（C 6 -C 20）芳基; R 8为P（= O）（OH）2，P（= O） = O）（O（C 1 -C 18）烷基（C 6 -C 20）芳基）2，P（= O）（OH）（OM）或P（= O）（OM）2，P = O（O 2 M）。

8. 发明申请

US20110235326A1 APPARATUS AND METHODS FOR CONTROLLING A THREE-DIMENSIONAL OPTICAL FIELD 有权
标题翻译：用于控制三维光学领域的装置和方法
公开(公告)号：US20110235326A1
公开(公告)日：2011-09-29
申请号：US13071561
申请日：2011-03-25
申请人： Jerliang Yeh , Ling-Yu Tsai , Min-Wei Hung , Chi-Hung Huang , Yu-Cheng Su
发明人： Jerliang Yeh , Ling-Yu Tsai , Min-Wei Hung , Chi-Hung Huang , Yu-Cheng Su
IPC分类号： F21V5/04
CPC分类号： F21V14/06 , G02B3/12 , G02B3/14 , G02B7/00 , G02B7/102 , G02B15/00 , G02B26/005 , G03B21/00 , G03B21/208
摘要： The present invention provides an apparatus for controlling a three-dimensional optical field. The apparatus includes a light-emission device and a set of zoom elements. The light-emission device emits a light. The set of zoom elements are disposed in front of the light-emission device, and focus the light from the light-emission device.
摘要翻译：本发明提供了一种用于控制三维光场的装置。该装置包括发光装置和一组变焦元件。发光装置发光。该组变焦元件设置在发光装置的前方，并且聚焦来自发光装置的光。

9. 发明申请

US20110044509A1 Bridge structural safety monitoring system and method thereof 有权
标题翻译：桥梁结构安全监测系统及其方法
公开(公告)号：US20110044509A1
公开(公告)日：2011-02-24
申请号：US12572437
申请日：2009-10-02
申请人： Chi-Hung Huang , Wei-Chieh Chiang , Tai-Shan Liao , Chia-Wei Hsu , Jen-Yu Wen , Tzu-Hsuan Wei , Yung-Hsiang Chen
发明人： Chi-Hung Huang , Wei-Chieh Chiang , Tai-Shan Liao , Chia-Wei Hsu , Jen-Yu Wen , Tzu-Hsuan Wei , Yung-Hsiang Chen
IPC分类号： G06K9/00
CPC分类号： G06T7/001 , E01D22/00 , G06T2207/10016 , G06T2207/30164
摘要： The present invention discloses a bridge structural safety monitoring system and a bridge structural safety monitoring method. The method includes the steps of capturing an image of a monitoring area of a bridge to create a standard image of the bridge operated at normal conditions, capturing images of the monitoring area of the bridge continuously to obtain monitoring images, comparing the standard image with the monitoring image to obtain a displacement correlation coefficient of the monitoring area of the bridge, and transmitting the displacement correlation coefficient to a central console, such that the central console can determine the using condition of the bridge according to the displacement correlation coefficient.
摘要翻译：本发明公开了一种桥梁结构安全监测系统和桥梁结构安全监测方法。该方法包括以下步骤：捕获桥的监视区域的图像，以创建在正常条件下操作的桥的标准图像，连续地捕获桥的监视区域的图像以获得监视图像，将标准图像与监测图像以获得桥梁监测区域的位移相关系数，并将位移相关系数传输到中央控制台，使得中央控制台可以根据位移相关系数确定桥梁的使用状况。

10. 发明授权

US08816289B2 Gamma dose rate measurement system 有权
标题翻译：伽玛剂量率测量系统
公开(公告)号：US08816289B2
公开(公告)日：2014-08-26
申请号：US13586268
申请日：2012-08-15
申请人： Din Ping Tsai , Chih-Chieh Wu , Chih-Chung Chou , Tai-Shan Liao , Chi-Hung Huang
发明人： Din Ping Tsai , Chih-Chieh Wu , Chih-Chung Chou , Tai-Shan Liao , Chi-Hung Huang
IPC分类号： G01T1/02
CPC分类号： G01T1/026 , G01T7/00
摘要： The present invention discloses a gamma dose rate measurement system comprising a shielding device and an electronic device. The shielding device is arranged for masking a visible light, so that only a light source substantially being a gamma ray passes through the shielding device. The electronic device comprises a sensing module, an image analysis module and a display module. The sensing module generates a current signal after sensing the gamma ray; the image analysis module receives the current signal and generates an analysis result including a total gamma dose rate and a gamma energy spectrum; and the display module is arranged for displaying the analysis result.
摘要翻译：本发明公开了一种包括屏蔽装置和电子装置的伽马剂量率测量系统。屏蔽装置被布置用于掩蔽可见光，使得仅基本上是伽马射线的光源通过屏蔽装置。电子设备包括感测模块，图像分析模块和显示模块。感测模块在感测伽马射线之后产生电流信号; 图像分析模块接收当前信号并产生包括总伽马剂量率和伽马能量谱的分析结果; 并且显示模块被布置用于显示分析结果。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式